Clinical Trial

A Clinical Study of Cizutamig in Thyroid Eye Disease

Name: A Clinical Study of Cizutamig in Thyroid Eye Disease — clinical trial record (NCT07597200)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with thyroid eye disease (TED).

Trial Details

NCT Number	NCT07597200
Lead Sponsor	Candid Therapeutics
Conditions	Thyroid Eye Disease, TED
Enrollment	38 participants
Start Date	2026-05-08
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-19